CVU mini – Friday 21 June 2024
MVEC’s upcoming CVU mini will be on the topic of RSV preventative therapies.
This half-day, face-to-face event offers healthcare professionals the opportunity to hear from leading experts on the latest in RSV prevention.
For regular updates from MVEC, subscribe to our newsletter or follow us @mvecau on Instagram and Twitter and at Melbourne Vaccine Education Centre – MVEC on Facebook.
Ticket information
Registration fee: from $125 per person ($375 for representatives from pharmaceutical companies)
Victorian regional immunisation providers can go in the running to win free registration by completing this short survey.
The competition closes Monday 29 April, and entrants will be notified of the outcome by Wednesday 1 May 2024.
Dietary requirements: Morning tea will be provided. Please advise of any dietary requirements when registering.
Following the event, we will email you a link to complete a short evaluation survey and an attendance certificate for professional development requirements.
Event details
Date: Friday 21 June 2024
Time: 9:25 am–12:30 pm AEDT (registration will open from 9:00 am)
Venue: Ella Latham auditorium, entry via HELP Precinct, Level 1, The Royal Children’s Hospital (RCH), 50 Flemington Road, Parkville
Please note: Parking is available onsite at RCH ($34 for full day); time-limited, on-street parking is available in the surrounding streets; RCH is accessible via tram routes 57, 58 and 59.
Attendees can submit questions for the panellists to respond to in the final session. Please submit your questions for the Q&A session before COB Wednesday 19 June 2024.
(If you are having trouble viewing the table on mobile, try rotating your screen to landscape mode, or view the web version on a computer instead.)
| June 2024 CVU mini program | |
| 9:00 am–9:25 am | Registration |
| 9:25 am–9:30 am | Acknowledgement of country and welcome Ms Rachael McGuire |
| 9:30 am–10:15 am | RSV preventative therapies for infants and children Presented by Prof Nigel Crawford |
| 10:15 am–10:45 am | RSV vaccines for adults Presented by Dr Julia Marshall |
| 10:45 am–11:15 am | Safety of RSV preventative therapies Presented by Dr Ingrid Laemmle-Ruff |
| 11:15 am–11:45 am | Morning tea |
| 11:45 am-12:30 pm | Q&A Moderated by Ms Rachael McGuire |
Ms Rachael McGuire
Education Nurse Coordinator, MVEC
Rachael is a Registered Nurse and accredited Nurse Immuniser with a Graduate Certificate in Clinical Education. She has experience immunising at local council, travel clinics and hospital immunisation services, including SAEFVIC. Her special interests lie in vaccine safety, the immunisation of special risk groups and vaccine equity. In 2023, Rachael’s enthusiasm for public health led to her involvement in DFAT-funded projects in Lao PDR, providing education and support to improve decision-making around immunisation policy.
Prof Nigel Crawford
Director, MVEC, Murdoch Children’s Research Institute
Nigel is a consultant general paediatrician and Head of the Immunisation service at the Royal Children’s Hospital in Melbourne, Australia. He completed a Masters of Public Health at Cardiff University (2006) and vaccinology PhD at the University of Melbourne (2011). He is also Director of SAEFVIC, the Victorian vaccine safety service, based at the Murdoch Children’s Research Institute (MCRI) and helped establish the Melbourne Vaccine Education Centre (MVEC). Nigel is a Professor at the Department of Paediatrics, University of Melbourne and his research interests include vaccine safety, immunisation of special risk groups and emerging infections, particularly those that may soon be vaccine preventable. He has been a member of the Australian Technical Advisory Group on Immunisation (ATAGI) since 2014 and became Chair in 2021.
Dr Julia Marshall
Human Infection Challenge Trial Consultant, The Peter Doherty Institute
Julia is a General Practitioner and Public Health Registrar and works as a Clinician-Scientist at The Peter Doherty Institute in vaccine development. For her PhD Julia developed the first controlled human infection model of aerosol BCG to aid in tuberculosis vaccine development and the world’s first SARS-CoV-2 human re-infection challenge model. She is a member of ATAGI.
Dr Ingrid Laemmle-Ruff
Immunisation Consultant, SAEFVIC, Murdoch Children’s Research Institute
Dr Ingrid Laemmle-Ruff is a general paediatrician and public health physician. She works in vaccine safety at SAEFVIC and in community paediatrics. She has interests in immunisation, immigrant health and child public health.
For regular updates from MVEC, subscribe to our newsletter or follow us @mvecau on Instagram and Twitter and at Melbourne Vaccine Education Centre – MVEC on Facebook.
MVEC is proud to be affiliated with the following partners as part of the CVU mini.
